Form 4: Nuvalent CEO James Richard Porter Executes Stock Option and Sells Shares Under 10b5-1 Plan

James Richard Porter, CEO of Nuvalent, Inc., exercised stock options and sold shares of Class A Common Stock under a pre-arranged 10b5-1 trading plan.

Summary

• On March 17, 2025, James Richard Porter, the President and CEO of Nuvalent, Inc. [NUVL], executed a stock option to acquire 27,000 shares of Class A Common Stock at an exercise price of $27.85.
• Simultaneously, Porter sold a total of 27,000 shares of Class A Common Stock in multiple transactions at weighted average prices ranging from $75.29 to $76.69.
• These transactions were conducted under a Rule 10b5-1 trading plan adopted on April 2, 2024.
• Following these transactions, Porter directly owns 249,062 shares of Class A Common Stock and holds options for 258,780 shares.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, as it's simply a factual disclosure.

Future Outlook

There is no future outlook provided in this document.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders. The use of 10b5-1 plans is a common practice to allow insiders to sell shares without being accused of trading on non-public information.

Comparison to Industry Standards

• Executive compensation packages in the pharmaceutical industry often include stock options as a significant component.
• The vesting schedule of the options (four years with monthly installments) is a standard practice to incentivize long-term commitment.
• The use of 10b5-1 trading plans is a common and accepted method for executives to manage their stock holdings while avoiding potential insider trading accusations, similar to practices at companies like Pfizer, Merck, and Johnson & Johnson.

Stakeholder Impact

• The sale of shares by the CEO could have a minor impact on shareholder sentiment, but the existence of a 10b5-1 plan mitigates concerns about insider trading.
• The transactions do not directly impact employees, customers, suppliers, or creditors.

Key Dates

Keywords

Form 4, Nuvalent, NUVL, James Richard Porter, Stock Option, 10b5-1 Trading Plan, Insider Trading, SEC Filing, Class A Common Stock, Executive Compensation